Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha

Prostaglandin F2alpha (PGF) causes luteolysis of the pig corpus luteum (CL) only after Day 12 of the estrous cycle. Recent evidence indicates that progesterone (P4) may protect the CL from cell death. The present study tested the hypothesis that acute inhibition of P4 by treatment with epostane (EPO...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biology of reproduction 2011-01, Vol.84 (1), p.26-33
Hauptverfasser: Diaz, Francisco J, Luo, Wenxiang, Wiltbank, Milo C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 33
container_issue 1
container_start_page 26
container_title Biology of reproduction
container_volume 84
creator Diaz, Francisco J
Luo, Wenxiang
Wiltbank, Milo C
description Prostaglandin F2alpha (PGF) causes luteolysis of the pig corpus luteum (CL) only after Day 12 of the estrous cycle. Recent evidence indicates that progesterone (P4) may protect the CL from cell death. The present study tested the hypothesis that acute inhibition of P4 by treatment with epostane (EPO; 3betaHSD inhibitor) in CL lacking luteolytic capacity (Day 9 CL) will allow PGF to induce responses associated with luteolysis. Multiple PGF-induced responses were evaluated, including genes involved in production of PGF and estradiol-17beta, apoptosis (caspase 3), and transcription (FOSB). These responses are associated with PGF-induced luteolysis and do not normally occur in CL lacking luteolytic capacity. Animals on Day 7 after estrus were divided into four groups: 1) control (C), 2) PGF, 3) EPO, and 4) PGF plus EPO (PGF+EPO). Treatment with EPO (10 mg/kg) or vehicle was given every 12 h for 36 h. Treatment with PGF (25 mg) or vehicle was given at 38 h, and CL were collected from all animals at 48 h. Some CL from each animal were frozen in liquid nitrogen for mRNA and protein analysis. Remaining CL were incubated in media for 2 h for determination of P4 and PGF production. EPO dramatically decreased production of P4 by luteal tissue (ng/mg tissue) by 90% and 95% in EPO and PGF+EPO groups, respectively, compared to C (P < 0.01). Low production of PGF by luteal tissue was found in C, PGF, and EPO groups; however, treatment with PGF+EPO dramatically increased (782%) luteal PGF production. Similar to intraluteal PGF production, increased mRNA for cyclooxygenase 2 (PTGS2) and phospholipase A2 (group IB; PLA2G1B) was found in the PGF+EPO, but not in the EPO or PGF, group. Aromatase (CYP19A1) mRNA was not induced by PGF or EPO; however, PGF+EPO caused a more than 40-fold increase in CYP19A1 mRNA (P < 0.01). CASP3 mRNA was increased (P < 0.01) by EPO (3.4-fold) and by PGF (2.7-fold) but was most dramatically increased by PGF+EPO (5.3-fold), whereas caspase activity was only increased by PGF (1.5-fold) or PGF+EPO (2.2-fold). Thus, these data support the hypothesis that elimination of the protective effect of intraluteal P4 does not directly cause luteolysis of the early CL but allows PGF to induce luteolytic responses in CL lacking luteolytic capacity.
doi_str_mv 10.1095/biolreprod.110.084368
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20739670</sourcerecordid><originalsourceid>FETCH-LOGICAL-f319t-7297eb5647bad8b3ec9e145156132c52ec05bd7931aa1c1fbdffaa061b6d31a83</originalsourceid><addsrcrecordid>eNpVkN1uEzEQhS0EomngEQDfcJnisXe9uzdIVUhLpUhUKr1ezXrtjZFjr2ynUl6DJ8Zpy9_VaGa-c45mCHkH7AJYV38abHBRzzGMF1BmrK2EbF-QBdS8WzVcti_JgjEmV0JIcUbOU_rBGFSCi9fkjLNGdLJhC_JzY4xWmQZDv2gVNSbrJ3rjc0R3yBodvY1h0inrGLymwdM77ZPN9sHm40mVd5puMLojvQ1R2cKsQ5wPiW6L_LCnOTwipy64Y7aKXqpsg08ncfFOGSeHfrSeXnF08w7fkFcGXdJvn-uS3F9tvq-_rrbfrm_Wl9uVEdDlcmPX6KGWVTPg2A5Cq05DVUMtQXBVc61YPYxNJwARFJhhNAaRSRjkWGatWJLPT77zYdjrUenHo_s52j3GYx_Q9v9vvN31U3joBQN-SlmS9_8a_FH-_m4BPj4DmBQ6E9Erm_5yopUVQFO4D0-cwdDjFAtzf8cZlKBO8AqY-AWRWpnk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>BioOne Complete</source><creator>Diaz, Francisco J ; Luo, Wenxiang ; Wiltbank, Milo C</creator><creatorcontrib>Diaz, Francisco J ; Luo, Wenxiang ; Wiltbank, Milo C</creatorcontrib><description>Prostaglandin F2alpha (PGF) causes luteolysis of the pig corpus luteum (CL) only after Day 12 of the estrous cycle. Recent evidence indicates that progesterone (P4) may protect the CL from cell death. The present study tested the hypothesis that acute inhibition of P4 by treatment with epostane (EPO; 3betaHSD inhibitor) in CL lacking luteolytic capacity (Day 9 CL) will allow PGF to induce responses associated with luteolysis. Multiple PGF-induced responses were evaluated, including genes involved in production of PGF and estradiol-17beta, apoptosis (caspase 3), and transcription (FOSB). These responses are associated with PGF-induced luteolysis and do not normally occur in CL lacking luteolytic capacity. Animals on Day 7 after estrus were divided into four groups: 1) control (C), 2) PGF, 3) EPO, and 4) PGF plus EPO (PGF+EPO). Treatment with EPO (10 mg/kg) or vehicle was given every 12 h for 36 h. Treatment with PGF (25 mg) or vehicle was given at 38 h, and CL were collected from all animals at 48 h. Some CL from each animal were frozen in liquid nitrogen for mRNA and protein analysis. Remaining CL were incubated in media for 2 h for determination of P4 and PGF production. EPO dramatically decreased production of P4 by luteal tissue (ng/mg tissue) by 90% and 95% in EPO and PGF+EPO groups, respectively, compared to C (P &lt; 0.01). Low production of PGF by luteal tissue was found in C, PGF, and EPO groups; however, treatment with PGF+EPO dramatically increased (782%) luteal PGF production. Similar to intraluteal PGF production, increased mRNA for cyclooxygenase 2 (PTGS2) and phospholipase A2 (group IB; PLA2G1B) was found in the PGF+EPO, but not in the EPO or PGF, group. Aromatase (CYP19A1) mRNA was not induced by PGF or EPO; however, PGF+EPO caused a more than 40-fold increase in CYP19A1 mRNA (P &lt; 0.01). CASP3 mRNA was increased (P &lt; 0.01) by EPO (3.4-fold) and by PGF (2.7-fold) but was most dramatically increased by PGF+EPO (5.3-fold), whereas caspase activity was only increased by PGF (1.5-fold) or PGF+EPO (2.2-fold). Thus, these data support the hypothesis that elimination of the protective effect of intraluteal P4 does not directly cause luteolysis of the early CL but allows PGF to induce luteolytic responses in CL lacking luteolytic capacity.</description><identifier>ISSN: 0006-3363</identifier><identifier>EISSN: 1529-7268</identifier><identifier>DOI: 10.1095/biolreprod.110.084368</identifier><identifier>PMID: 20739670</identifier><identifier>CODEN: BIREBV</identifier><language>eng</language><publisher>Madison, WI: Society for the Study of Reproduction, Inc</publisher><subject>Androstenols - administration &amp; dosage ; Androstenols - pharmacology ; Animals ; Biological and medical sciences ; Caspase 3 - genetics ; Caspase 3 - metabolism ; Corpus Luteum - drug effects ; Corpus Luteum - physiology ; Dinoprost - administration &amp; dosage ; Dinoprost - pharmacology ; Female ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation - drug effects ; Gene Expression Regulation - physiology ; Luteolysis - drug effects ; Luteolysis - physiology ; Phosphoproteins - genetics ; Phosphoproteins - metabolism ; Progesterone - blood ; Progesterone - metabolism ; Proto-Oncogene Proteins c-fos - genetics ; Proto-Oncogene Proteins c-fos - metabolism ; Swine - physiology ; Vertebrates: reproduction</subject><ispartof>Biology of reproduction, 2011-01, Vol.84 (1), p.26-33</ispartof><rights>2015 INIST-CNRS</rights><rights>2011 by the Society for the Study of Reproduction, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23864117$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20739670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Diaz, Francisco J</creatorcontrib><creatorcontrib>Luo, Wenxiang</creatorcontrib><creatorcontrib>Wiltbank, Milo C</creatorcontrib><title>Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha</title><title>Biology of reproduction</title><addtitle>Biol Reprod</addtitle><description>Prostaglandin F2alpha (PGF) causes luteolysis of the pig corpus luteum (CL) only after Day 12 of the estrous cycle. Recent evidence indicates that progesterone (P4) may protect the CL from cell death. The present study tested the hypothesis that acute inhibition of P4 by treatment with epostane (EPO; 3betaHSD inhibitor) in CL lacking luteolytic capacity (Day 9 CL) will allow PGF to induce responses associated with luteolysis. Multiple PGF-induced responses were evaluated, including genes involved in production of PGF and estradiol-17beta, apoptosis (caspase 3), and transcription (FOSB). These responses are associated with PGF-induced luteolysis and do not normally occur in CL lacking luteolytic capacity. Animals on Day 7 after estrus were divided into four groups: 1) control (C), 2) PGF, 3) EPO, and 4) PGF plus EPO (PGF+EPO). Treatment with EPO (10 mg/kg) or vehicle was given every 12 h for 36 h. Treatment with PGF (25 mg) or vehicle was given at 38 h, and CL were collected from all animals at 48 h. Some CL from each animal were frozen in liquid nitrogen for mRNA and protein analysis. Remaining CL were incubated in media for 2 h for determination of P4 and PGF production. EPO dramatically decreased production of P4 by luteal tissue (ng/mg tissue) by 90% and 95% in EPO and PGF+EPO groups, respectively, compared to C (P &lt; 0.01). Low production of PGF by luteal tissue was found in C, PGF, and EPO groups; however, treatment with PGF+EPO dramatically increased (782%) luteal PGF production. Similar to intraluteal PGF production, increased mRNA for cyclooxygenase 2 (PTGS2) and phospholipase A2 (group IB; PLA2G1B) was found in the PGF+EPO, but not in the EPO or PGF, group. Aromatase (CYP19A1) mRNA was not induced by PGF or EPO; however, PGF+EPO caused a more than 40-fold increase in CYP19A1 mRNA (P &lt; 0.01). CASP3 mRNA was increased (P &lt; 0.01) by EPO (3.4-fold) and by PGF (2.7-fold) but was most dramatically increased by PGF+EPO (5.3-fold), whereas caspase activity was only increased by PGF (1.5-fold) or PGF+EPO (2.2-fold). Thus, these data support the hypothesis that elimination of the protective effect of intraluteal P4 does not directly cause luteolysis of the early CL but allows PGF to induce luteolytic responses in CL lacking luteolytic capacity.</description><subject>Androstenols - administration &amp; dosage</subject><subject>Androstenols - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Caspase 3 - genetics</subject><subject>Caspase 3 - metabolism</subject><subject>Corpus Luteum - drug effects</subject><subject>Corpus Luteum - physiology</subject><subject>Dinoprost - administration &amp; dosage</subject><subject>Dinoprost - pharmacology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene Expression Regulation - physiology</subject><subject>Luteolysis - drug effects</subject><subject>Luteolysis - physiology</subject><subject>Phosphoproteins - genetics</subject><subject>Phosphoproteins - metabolism</subject><subject>Progesterone - blood</subject><subject>Progesterone - metabolism</subject><subject>Proto-Oncogene Proteins c-fos - genetics</subject><subject>Proto-Oncogene Proteins c-fos - metabolism</subject><subject>Swine - physiology</subject><subject>Vertebrates: reproduction</subject><issn>0006-3363</issn><issn>1529-7268</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkN1uEzEQhS0EomngEQDfcJnisXe9uzdIVUhLpUhUKr1ezXrtjZFjr2ynUl6DJ8Zpy9_VaGa-c45mCHkH7AJYV38abHBRzzGMF1BmrK2EbF-QBdS8WzVcti_JgjEmV0JIcUbOU_rBGFSCi9fkjLNGdLJhC_JzY4xWmQZDv2gVNSbrJ3rjc0R3yBodvY1h0inrGLymwdM77ZPN9sHm40mVd5puMLojvQ1R2cKsQ5wPiW6L_LCnOTwipy64Y7aKXqpsg08ncfFOGSeHfrSeXnF08w7fkFcGXdJvn-uS3F9tvq-_rrbfrm_Wl9uVEdDlcmPX6KGWVTPg2A5Cq05DVUMtQXBVc61YPYxNJwARFJhhNAaRSRjkWGatWJLPT77zYdjrUenHo_s52j3GYx_Q9v9vvN31U3joBQN-SlmS9_8a_FH-_m4BPj4DmBQ6E9Erm_5yopUVQFO4D0-cwdDjFAtzf8cZlKBO8AqY-AWRWpnk</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Diaz, Francisco J</creator><creator>Luo, Wenxiang</creator><creator>Wiltbank, Milo C</creator><general>Society for the Study of Reproduction, Inc</general><general>Society for the Study of Reproduction</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20110101</creationdate><title>Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha</title><author>Diaz, Francisco J ; Luo, Wenxiang ; Wiltbank, Milo C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-f319t-7297eb5647bad8b3ec9e145156132c52ec05bd7931aa1c1fbdffaa061b6d31a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Androstenols - administration &amp; dosage</topic><topic>Androstenols - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Caspase 3 - genetics</topic><topic>Caspase 3 - metabolism</topic><topic>Corpus Luteum - drug effects</topic><topic>Corpus Luteum - physiology</topic><topic>Dinoprost - administration &amp; dosage</topic><topic>Dinoprost - pharmacology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene Expression Regulation - physiology</topic><topic>Luteolysis - drug effects</topic><topic>Luteolysis - physiology</topic><topic>Phosphoproteins - genetics</topic><topic>Phosphoproteins - metabolism</topic><topic>Progesterone - blood</topic><topic>Progesterone - metabolism</topic><topic>Proto-Oncogene Proteins c-fos - genetics</topic><topic>Proto-Oncogene Proteins c-fos - metabolism</topic><topic>Swine - physiology</topic><topic>Vertebrates: reproduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diaz, Francisco J</creatorcontrib><creatorcontrib>Luo, Wenxiang</creatorcontrib><creatorcontrib>Wiltbank, Milo C</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biology of reproduction</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diaz, Francisco J</au><au>Luo, Wenxiang</au><au>Wiltbank, Milo C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha</atitle><jtitle>Biology of reproduction</jtitle><addtitle>Biol Reprod</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>84</volume><issue>1</issue><spage>26</spage><epage>33</epage><pages>26-33</pages><issn>0006-3363</issn><eissn>1529-7268</eissn><coden>BIREBV</coden><abstract>Prostaglandin F2alpha (PGF) causes luteolysis of the pig corpus luteum (CL) only after Day 12 of the estrous cycle. Recent evidence indicates that progesterone (P4) may protect the CL from cell death. The present study tested the hypothesis that acute inhibition of P4 by treatment with epostane (EPO; 3betaHSD inhibitor) in CL lacking luteolytic capacity (Day 9 CL) will allow PGF to induce responses associated with luteolysis. Multiple PGF-induced responses were evaluated, including genes involved in production of PGF and estradiol-17beta, apoptosis (caspase 3), and transcription (FOSB). These responses are associated with PGF-induced luteolysis and do not normally occur in CL lacking luteolytic capacity. Animals on Day 7 after estrus were divided into four groups: 1) control (C), 2) PGF, 3) EPO, and 4) PGF plus EPO (PGF+EPO). Treatment with EPO (10 mg/kg) or vehicle was given every 12 h for 36 h. Treatment with PGF (25 mg) or vehicle was given at 38 h, and CL were collected from all animals at 48 h. Some CL from each animal were frozen in liquid nitrogen for mRNA and protein analysis. Remaining CL were incubated in media for 2 h for determination of P4 and PGF production. EPO dramatically decreased production of P4 by luteal tissue (ng/mg tissue) by 90% and 95% in EPO and PGF+EPO groups, respectively, compared to C (P &lt; 0.01). Low production of PGF by luteal tissue was found in C, PGF, and EPO groups; however, treatment with PGF+EPO dramatically increased (782%) luteal PGF production. Similar to intraluteal PGF production, increased mRNA for cyclooxygenase 2 (PTGS2) and phospholipase A2 (group IB; PLA2G1B) was found in the PGF+EPO, but not in the EPO or PGF, group. Aromatase (CYP19A1) mRNA was not induced by PGF or EPO; however, PGF+EPO caused a more than 40-fold increase in CYP19A1 mRNA (P &lt; 0.01). CASP3 mRNA was increased (P &lt; 0.01) by EPO (3.4-fold) and by PGF (2.7-fold) but was most dramatically increased by PGF+EPO (5.3-fold), whereas caspase activity was only increased by PGF (1.5-fold) or PGF+EPO (2.2-fold). Thus, these data support the hypothesis that elimination of the protective effect of intraluteal P4 does not directly cause luteolysis of the early CL but allows PGF to induce luteolytic responses in CL lacking luteolytic capacity.</abstract><cop>Madison, WI</cop><pub>Society for the Study of Reproduction, Inc</pub><pmid>20739670</pmid><doi>10.1095/biolreprod.110.084368</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-3363
ispartof Biology of reproduction, 2011-01, Vol.84 (1), p.26-33
issn 0006-3363
1529-7268
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3012561
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; BioOne Complete
subjects Androstenols - administration & dosage
Androstenols - pharmacology
Animals
Biological and medical sciences
Caspase 3 - genetics
Caspase 3 - metabolism
Corpus Luteum - drug effects
Corpus Luteum - physiology
Dinoprost - administration & dosage
Dinoprost - pharmacology
Female
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation - drug effects
Gene Expression Regulation - physiology
Luteolysis - drug effects
Luteolysis - physiology
Phosphoproteins - genetics
Phosphoproteins - metabolism
Progesterone - blood
Progesterone - metabolism
Proto-Oncogene Proteins c-fos - genetics
Proto-Oncogene Proteins c-fos - metabolism
Swine - physiology
Vertebrates: reproduction
title Effect of Decreasing Intraluteal Progesterone on Sensitivity of the Early Porcine Corpus Luteum to the Luteolytic Actions of Prostaglandin F2alpha
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A31%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Decreasing%20Intraluteal%20Progesterone%20on%20Sensitivity%20of%20the%20Early%20Porcine%20Corpus%20Luteum%20to%20the%20Luteolytic%20Actions%20of%20Prostaglandin%20F2alpha&rft.jtitle=Biology%20of%20reproduction&rft.au=Diaz,%20Francisco%20J&rft.date=2011-01-01&rft.volume=84&rft.issue=1&rft.spage=26&rft.epage=33&rft.pages=26-33&rft.issn=0006-3363&rft.eissn=1529-7268&rft.coden=BIREBV&rft_id=info:doi/10.1095/biolreprod.110.084368&rft_dat=%3Cpubmed_pasca%3E20739670%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/20739670&rfr_iscdi=true